A Phase 2 Randomized, Open-Label, Exploratory Trial of GS-5885, GS-9451 with Peginterferon Alfa 2a (PEG) and Ribavirin (RBV) in Treatment-Naive Subjects with Chronic Genotype 1 Hepatitis C Virus ..
- Lubel, John (Primary Chief Investigator (PCI))
Project: Research